Fintel reports that on December 11, 2025, Citigroup upgraded their outlook for Thermo Fisher Scientific (NYSE:TMO) from Neutral to Buy.
Analyst Price Forecast Suggests 9.04% Upside
As of December 6, 2025, the average one-year price target for Thermo Fisher Scientific is $631.27/share. The forecasts range from a low of $538.49 to a high of $708.75. The average price target represents an increase of 9.04% from its latest reported closing price of $578.91 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Thermo Fisher Scientific is 48,792MM, an increase of 11.56%. The projected annual non-GAAP EPS is 28.08.
What is the Fund Sentiment?
There are 3,708 funds or institutions reporting positions in Thermo Fisher Scientific. This is an decrease of 48 owner(s) or 1.28% in the last quarter. Average portfolio weight of all funds dedicated to TMO is 0.52%, an increase of 3.72%. Total shares owned by institutions decreased in the last three months by 1.81% to 380,491K shares. 
The put/call ratio of TMO is 1.27, indicating a bearish outlook.
What are Other Shareholders Doing?
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 12,136K shares representing 3.23% ownership of the company. In its prior filing, the firm reported owning 11,913K shares , representing an increase of 1.84%. The firm decreased its portfolio allocation in TMO by 25.94% over the last quarter.
VFINX - Vanguard 500 Index Fund Investor Shares holds 10,716K shares representing 2.85% ownership of the company. In its prior filing, the firm reported owning 10,627K shares , representing an increase of 0.82%. The firm decreased its portfolio allocation in TMO by 27.01% over the last quarter.
Capital World Investors holds 10,285K shares representing 2.74% ownership of the company. In its prior filing, the firm reported owning 9,579K shares , representing an increase of 6.87%. The firm increased its portfolio allocation in TMO by 20.70% over the last quarter.
Geode Capital Management holds 8,170K shares representing 2.17% ownership of the company. In its prior filing, the firm reported owning 8,115K shares , representing an increase of 0.68%. The firm increased its portfolio allocation in TMO by 9.62% over the last quarter.
Jpmorgan Chase holds 7,273K shares representing 1.94% ownership of the company. In its prior filing, the firm reported owning 9,154K shares , representing a decrease of 25.86%. The firm decreased its portfolio allocation in TMO by 90.80% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
